BIOMAT Database Logo BIOMAT Database Logo

Single-domain antibodies for biomedical applications. 2016

Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
a Protein Engineering and Antibody Technologies , Merck-Serono, Merck KGaA, Darmstadt , Germany .

Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.

UI MeSH Term Description Entries
D002162 Camelus Two-toed, hoofed mammals with four legs, a big-lipped snout, and a humped back belonging to the family Camelidae. They are native to North Africa, and Western and Central Asia. Camels,Dromedary,Bactrian Camels,Bractrian Camels,Camelus bactrianus,Camelus dromedarius,Bactrian Camel,Bractrian Camel,Camel,Camel, Bactrian,Camel, Bractrian,Camels, Bactrian,Camels, Bractrian,Dromedaries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012754 Sharks A group of elongate elasmobranchs. Sharks are mostly marine fish, with certain species large and voracious. Shark
D057127 Single-Chain Antibodies A form of antibodies consisting only of the variable regions of the heavy and light chains (FV FRAGMENTS), connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use. Fv Antibody Fragments, Single-Chain,ScFv Antibodies,Single-Chain Fv,Single-Chain Fv Antibody,Single-Chain Fv Antibody Fragments,Single-Chain Variable Fragment,Single-Chain Variable Fragment Antibodies,Single-Chain Variable Fragment Antibody,Single-Chain Variable Fragments,Antibodies, ScFv,Antibodies, Single-Chain,Antibody, Single-Chain Fv,Fragment, Single-Chain Variable,Fragments, Single-Chain Variable,Fv Antibody Fragments, Single Chain,Fv Antibody, Single-Chain,Fv, Single-Chain,Single Chain Antibodies,Single Chain Fv,Single Chain Fv Antibody,Single Chain Fv Antibody Fragments,Single Chain Variable Fragment,Single Chain Variable Fragment Antibodies,Single Chain Variable Fragment Antibody,Single Chain Variable Fragments,Variable Fragment, Single-Chain,Variable Fragments, Single-Chain

Related Publications

Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
[Prospective Applications of Single-Domain Antibodies in Biomedicine].
January 2020, Molekuliarnaia biologiia,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
An Inside Job: Applications of Intracellular Single Domain Antibodies.
December 2020, Biomolecules,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Editorial: Single-Domain Antibodies-Biology, Engineering and Emerging Applications.
January 2018, Frontiers in immunology,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.
January 2017, Frontiers in immunology,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Single-cell droplet microfluidics for biomedical applications.
May 2022, The Analyst,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Diagnostic and biomedical applications: monoclonal antibodies.
January 1983, Biotechnology advances,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Single domain antibodies.
April 1990, BMJ (Clinical research ed.),
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Single domain antibodies.
December 1989, Lancet (London, England),
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Fluorescent single-digit detonation nanodiamond for biomedical applications.
May 2018, Methods and applications in fluorescence,
Simon Krah, and Christian Schröter, and Stefan Zielonka, and Martin Empting, and Bernhard Valldorf, and Harald Kolmar
Engineering Single-Atom Nanozymes for Catalytic Biomedical Applications.
July 2023, Small (Weinheim an der Bergstrasse, Germany),
Copied contents to your clipboard!